Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heat Stable Carbetocin vs Oxytocin for PPH Prevention in Emergency C-Section
NCT03755531Phase 4Completed
- Sponsor
- Al-Kindy College of Medicine
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Al-Kindy College of Medicine. Primary endpoints: Blood loss equal or more than 1000 ml at 24 hours and Use of additional uterotonics at 24 hours. Started Jan 2018; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03755531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755531.